{"id":34874,"date":"2020-11-10T15:11:53","date_gmt":"2020-11-10T15:11:53","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=34874"},"modified":"2021-03-18T12:11:06","modified_gmt":"2021-03-18T12:11:06","slug":"vincent-von-walcke-wulffen","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/","title":{"rendered":"Vincent von Walcke-Wulffen"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>Dr. Vincent von Walcke-Wulffen<\/h2>\n<h4>CEO at BioKryo GmbH<\/h4>\n\t<p>Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group &#8220;Cryobank&#8221;. He represented Fraunhofer- at the BBMRI and in the ISO working group.<\/p>\n<p>Since 2010 he is founder and managing director of BioKryo GmbH. BioKryo is a commercial GMP-biobank for the storage of cryopreserved samples for later diagnostic and therapeutic use. Since 2019 BioKryo GmbH is part of the Air Liquide Biobanking Network.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2.jpg\" alt=\"Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-201&#215;300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-686&#215;1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-768&#215;1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-630&#215;940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-420&#215;627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo_BioTech_Pharma_Summit_2-315&#215;470.jpg 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Building a GMP Biobanking Network in Europe\n\t<\/h3>\n\t<p>Inside the Air Liquide Group a unique european network of Biobanks is developing. Each of these Biobanks aim to support the storage and distriubtion of drugs and samples on the highest level. For this internal standards based on the GMP rules were defined and interactions points defined.<\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.biokryo.de\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.biokryo.de\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/vincent-von-walcke-wulffen-9a855b\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit Profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Dr. Vincent von Walcke-Wulffen CEO at BioKryo GmbH Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group &#8220;Cryobank&#8221;. He represented Fraunhofer- at the BBMRI and in the ISO working group. Since 2010 he is founder and managing director of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33097,"parent":34845,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-34874","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group &quot;Cryobank&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group &quot;Cryobank&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-18T12:11:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/\",\"name\":\"Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg\",\"datePublished\":\"2020-11-10T15:11:53+00:00\",\"dateModified\":\"2021-03-18T12:11:06+00:00\",\"description\":\"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group \\\"Cryobank\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDx\/Biomarkers &#038; Biobanking 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Vincent von Walcke-Wulffen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit","description":"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group \"Cryobank\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/","og_locale":"en_US","og_type":"article","og_title":"Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit","og_description":"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group \"Cryobank\".","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-18T12:11:06+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/","name":"Vincent von Walcke-Wulffen &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg","datePublished":"2020-11-10T15:11:53+00:00","dateModified":"2021-03-18T12:11:06+00:00","description":"Dr. Vincent von Walcke-Wulffen studied at the University of Hamburg. In 2004 he became a research assistant at the Fraunhofer IBMT in the working group \"Cryobank\".","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Vincent_von_Walcke_Wulffen_Biokryo.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/vincent-von-walcke-wulffen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"CDx\/Biomarkers &#038; Biobanking 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/cdx-biomarkers-biobanking-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Vincent von Walcke-Wulffen"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=34874"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34874\/revisions"}],"predecessor-version":[{"id":36044,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34874\/revisions\/36044"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33097"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=34874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}